Search Results for: mira

Clarifying the Due Date for MIRA Applications from New and Early Stage Investigators

The September 9 receipt date for the Maximizing Investigators’ Research Award (MIRA) for New and Early Stage Investigators (R35) is just one week away! We recommend that applicants submit a few days early to give themselves time to check that their applications as received by NIH are complete and correct. A few points of clarification …

MIRA Webinar, Other Resources for New and Early Stage Investigators

UPDATE: Due to technical difficulties, the MIRA webinar was not recorded. We have posted the slides on the MIRA Web page, where we’ll also post a summary of the webinar questions and answers. NIGMS Director Jon Lorsch and I will field questions about the recently announced Maximizing Investigators’ Research Award (MIRA) for New and Early …

MIRA Pilot Adds New and Early Stage Investigators

We have just expanded the pilot of our Maximizing Investigators’ Research Award (MIRA) to include new and early stage investigators. The application due date is September 9, and we request—but do not require—letters of intent by August 9. MIRA supports investigators’ overall research programs through a single, unified grant rather than individual project grants. The …

MIRA Webinar and Other Resources

NIGMS Director Jon Lorsch and I will field your questions about the recently announced Maximizing Investigators’ Research Award (MIRA) (R35) during a webinar on Thursday, Feb. 19, from 2-3 p.m. EST. You’ll be able to access the webinar at https://webmeeting.nih.gov/nigmsmira/. During the event, you can submit questions by calling 301-451-4301 or e-mailing me. You also …

Application and Funding Trends in Fiscal Year 2021

NIGMS maintains a diverse biomedical research portfolio, supporting a wide range of topics and investigators. In Fiscal Year (FY) 2021, NIGMS received a congressional appropriation of $2,991,417,000. As part of the Consolidated Appropriations Act, 2022, this budget increased by 3.4% to $3,092,373,000 for FY 2022. The majority of these funds support research project grants (RPGs) at …

NIGMS Funding Opportunities for Technology Development and Upcoming Webinar

UPDATE: The video and slides [PDF] for this webinar are now available. We’re pleased to share that NIGMS has reissued two funding opportunity announcements (FOAs) for our technology development program. Both FOAs support the development of novel technologies with the potential for broad utility in biomedical research. They are: Technology Development Research for Establishing Feasibility …

Application and Funding Trends in Fiscal Year 2020

On December 27, 2020, the Consolidated Appropriations Act, 2021, was signed into law. The appropriation provides NIGMS with a budget of $2,991,417,000, in Fiscal Year (FY) 2021, a 1.8% increase over the FY 2020 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research. …

Funding Opportunities: Addressing Structural Racism and Discrimination

UPDATE: The funding opportunity, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) (RFA-MD-21-004), is now available. A pre-application technical assistance workshop will be held on May 26, 1-2:30 p.m. ET. See NOT-MD-21-018 for details. We want to make you aware of two funding …